Markers of Peritoneal Membrane Status

Gotloib L. , Digenis G.E. , Rabinovich S. , Medline A. , Oreopoulos D.G. Ultrastructure of normal rabbit mesentery. Nephron 1983; 34: 248–55.

Dobbie J.W. Morphology of the peritoneum in CAPD. Blood Purif 1989; 7: 74–85.

Dobbie J.W. , Lloyd J.K. , Gall C.A. Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients. In: Khanna R. , Nolph K.D. , Prowant B.F. , Twardowski Z.J. , Oreopoulos D.G. eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin Inc., 1990; 6: 3–12.

Laurent T.C. II The ultrastructure and physical-chemical properties of interstitial connective tissue. Pflugers Arch 1972; 336(Suppl): S21–S42.

Dobbie J.W. , Zaki M. , Wilson L. Ultrastructural studies on the peritoneum with special reference to chronic ambulatory peritoneal dialysis. Scott Med J 1981; 26: 213–23.

Dobbie J.W. , Anderson J.D. , Hind C. Long-term effects of peritoneal dialysis on peritoneal morphology. Perit Dial Int 1994; 14(Suppl 3): S16–S20.

Di Paolo N. , Sacchi G. , De Mia M. Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron 1986; 44: 204–11.

Gotloib L. , Shostak A. , Bar-Sella P. , Cohen R. Continuous mesothelial injury and regelation during long term peritoneal dialysis. Perit Dial Bull 1987; 7: 148–55.

Pollock C.A. , Ibels L.S. , Eckstein R.P. Peritoneal morphology on maintenance dialysis. Am J Nephrol 1989; 9: 198–204.

Gotloib L. , Shostak A. , Bar-Sella P. , Eiali V. Fenestrated capillaries in human parietal and rabbit diaphragmatic peritoneum. Nephron 1985; 41: 200–2.

Gotloib L. , Bar-Sella P. , Shostak A. Reduplicated basal lamina of small venules and mesothelium of human parietal peritoneum. Perit Dial Bull 1985; 5: 212–15.

Di Paolo N. , Sacchi G. Peritoneal vascular changes in continuous ambulatory peritoneal dialysis (CAPD): an in vivo model for the study of diabetic microangiopathy. Perit Dial Int 1989; 9: 41–5.

Grahame G.R. , Torchia M.G. , Dankewich K.A. , Ferguson I.A. Surface-active material in peritoneal effluent of CAPD patients. Perit Dial Bull 1985; 5: 109–11.

Di Paolo N. , Buoncristiani U. , Capotondo L. Phosphatidylcholine and peritoneal transport during peritoneal dialysis. Nephron 1986; 44: 365–70.

Williams J.D. , Beavis J.M. Phosphatidylcholine and peritoneal dialysis. Contrib Nephrol 1990; 85: 142–9.

Beavis J. , Harwood J.L. , Coles G.A. , Williams J.D. Synthesis of phospholipids by human peritoneal mesothelial cells. Perit Dial Int 1994; 14: 348–55.

Dobbie J.W. , Pavlina T. , Lloyd J.K. , Johnston R.C. Phosphatidylcholine synthesis by peritoneal mesothelium: its implications for peritoneal dialysis. Am J Kidney Dis 1988; 12: 31–6.

Dobbie J.W. , Lloyd J.K. Mesothelium secretes lamellar bodies in a similar manner to type II pneumocyte secretion of surfactant. Perit Dial Int 1989; 9: 215–19.

Kabawat S.E. , Bast R.C. , Welch W.R. , Knapp R.C. , Colvin R.B. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid and clear cell types. Am J Clin Pathol 1983; 79: 98–104.

Kabawat S.E. , Bast R.C. , Bhan A.K. , Welch W.R. , Knapp R.C. , Colvin R.B. Tissue distribution of a coelomicepithelium-related antigen recognized by the monoclonal antibody OC 125. Int J Gynecol Pathol 1983; 2: 275–85.

Koomen G.C.M. , Betjes M.G.H. , Zemel D. , Krediet R.T. , Hoek F.J. Cancer antigen 125 is locally produced in the peritoneal cavity during continuous ambulatory peritoneal dialysis. Perit Dial Int 1994; 14: 132–6.

Visser C.E. , Brouwer-Steenbergen J.J.E. , Betjes M.G.H. , Koomen G.C.M. , Beelen R.H.J. , Krediet R.T. Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patientsNephrol Dial Transplant 1995; 10: 64–9.

Lye W.C. , Tambyah P. , Leong S.O. , Lee E.J.C. Serum tumor markers in patients on dialysis and kidney transplantation. In: Khanna R. ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications Inc., 1994; 10: 109–11.

Staprans I. , Piel C.F. , Felts J.M. Analysis of selected plasma constituents in continuous ambulatory peritoneal dialysis effluent. Am J Kidney Dis 1986; 7: 490–4.

Davies M. , Stylianou E. , Yung S. , Thomas G.J. , Coles G.A. , Williams J.D. Proteoglycans of CAPD-dialysate fluid and mesothelium. Contrib Nephrol 1990; 85: 131–41.

Lipkin G.W. , Forbes M.A. , Cooper E.H. , Turney J.H. Hyaluronic acid metabolism and its clinical significance in patients treated by continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1993; 8: 357–60.

Yung S. , Coles G.A. , Williams J.D. , Davies M. The source and possible significance of hyaluronan in the peritoneal cavity. Kidney Int 1994; 46: 527–33.

Roboz J. , Greaves J. , Silides D. , Chahinian A.P. , Holland J.F. Hyaluronic acid content of effusion as a diagnostic aid for malignant mesothelioma. Cancer Res 1985; 45: 1850–4.

Yung S. , Thomas G.J. , Stylianou E. , Williams J.D. , Coles G.A. , Davies M. Source of peritoneal proteoglycans. Human peritoneal mesothelial cells synthesize and secrete mainly small dermatan sulfate proteoglycans. Am J Pathol 1995; 146: 520–9.

Douvdevani A. , Rapoport J. , Konforti A. , Argov S. , Ovnat A. , Chaimovitz C. Human peritoneal mesothelial cells synthesize IL-lα and β. Kidney Int 1994; 46: 993–1001.

Topley N. , Jörres A. , Luttmann W. Human peritoneal mesothelial cells synthesize IL-6: induction by IL-lβ and TNFα. Kidney Int 1993; 43: 226–33.

Betjes M.G.H. , Tuk C.W. , Struijk D.G. Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-α, interleukin-l, and medium conditioned by macrophages cocultured with Staphylococcus epidermidis. J Infect Dis 1993; 168: 1202–10.

Topley N. , Brown Z. , Jörres A. Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1β and tumor necrosis factor-α. Am J Pathol 1993; 142: 1876–86.

Stylianou E. , Mackenzie R.K. , Davies M. , Coles G.A. , Williams J.D. The interaction of organism, phagocyte and mesothelial cell. Contrib Nephrol 1990; 85: 30–8.

Topley N. , Jörres A. , Petersen M.M. Human peritoneal mesothelial cell prostaglandin metabolism: induction by cytokines and peritoneal macrophage conditioned medium. (Abstract) J Am Soc Nephrol 1991; 2: 432.

Shaldon S. , Dinarello C.A. , Wyler D.J. Induction of interleukin-l during CAPD. Contrib Nephrol 1987; 57: 207–12.

Goldman M. , Vandenabeele P. , Moulart J. Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis. Nephron 1990; 56: 277–80.

Zemel D. , ten Berge R.J.M. , Struijk D.G. , Bloemena E. , Koomen G.C.M. , Krediet R.T. Interleukin-6 in CAPD patients without peritonitis; relationship to the intrinsic permeability of the peritoneal membrane. Clin Nephrol 1992; 37: 97–103.

Lin C.Y. , Lin C.C. , Huang T.P. Serial changes of interleukin-6 and interleukin-Slevels in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis. Nephron 1993; 63: 404–8.

Zemel D. , Krediet R.T. , Koomen G.C.M. , Kortekaas W.M.R. , Geertzen H.G.M. , ten Berge R.J.M. Interleukin-8 during peritonitis in patients treated with CAPD; an in vivo model of acute inflammation. Nephrol Dial Transplant 1994; 9: 169–74.

Brauner A. , Hylander B. , Wretlind B. Interleukin-6 and interleukin-8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1993; 22: 430–5.

Steinhauer H.B. , Günter B. , Schollmeyer P. Stimulation of peritoneal synthesis of vasoactive prostaglandins during peritonitis in patients on continuous ambulatory peritoneal dialysis. Eur J ClinInvest 1985; 15: 1–15.

Steinhauer H.B. , Schollmeyer P. Prostaglandin-mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysis. Kidney Int 1986; 29: 584–90.

Zemel D. , Krediet R.T. Cytokine patterns in the effluent of CAPD patients; relationship to peritoneal permeability. Blood Purif (in press).

Zemel D. , Imholz A.L.T. , de Waart D.R. , Dinkla C. , Struijk D.G. , Krediet R.T. Appearance of tumor necrosis factor-α and soluble TNF -receptors I and II in peritoneal effluent of CAPD. Kidney Int 1994; 46: 1422–30.

Topley N. , Witowski J. , Jörres A. , Mackenzie R. , Coles G.A. , Williams J.D. Synthesis of IL-6 by human peritoneal mesothelial cells: superinduction by spent dialysate and peritoneal macrophage derived cytokines. (Abstract) J Am Soc Nephrol 1993; 4: 419.

Herbelin A. , N guyen A.T. , Zingraff J. , Ureña P. , Deschamps-Latscha B. Influence of uremia and hemodialysis on circulating interleukin-l and tumor necrosis factor α. Kidney Int 1990; 37: 116–25.

Pereira B.J.G. , Shapiro L.S. , King A.J. , Falagas M.E. , Strom J.A. , Dinarello C.A. Plasma levels of IL-Iβ, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 1994; 45: 890–6.

Herbelin A. , Ureña P. , Nguyen A.T. , Zingraff J. , Deschamps-Latscha B. Elevated levels of interleukin 6 in patients with chronic renal failure. Kidney Int 1991; 39: 954–60.

Zemel D. , ten Berge R.J.M. , Koomen G.C.M. , Struijk D.G. , Krediet R.T. Serum interleukin-6 in continuous ambulatory peritoneal dialysis patients. Nephron 1993; 64: 320–1.

Gries E. , Kopp J. , Thomae U. , Kuhlman H. Relation of intraperitoneal and intravascular coagulation and fibrinolysis related antigens in peritoneal dialysis. Thromb Haemost 1990; 63: 356–60.

Sitter T. , Spannagl M. , Schiffl H. , Held E. , van Hinsbergh VWM Van , Kóoistra T. Disbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients: the role of mesothelial cells. Nephrol Dial Transplant 1995; 10: 677–83.

van Hinsbergh W.M. , Kooistra T. , Scheffer M.A. , van Bockel J.H. , van Muijen G.N.P. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood 1990; 75: 1490–7.

Slater N.D. , Cope G.H. , Raftery A.T. Peritoneal plasminogen activator activity after chronic exposure to dialysis fluid. Perit Dial Int 1992; 12: 203–63.

Jörres A. , Ludat K. , Topley N. Human peritoneal fibroblasts synthesize the chemotactic peptide interleukin-8. (Abstract) Nephrol Dial Transplant 1994; 9: 1022.

Ludat K. , Topley N. , Lang J. , Gahl G.M. , Frei U. , Jörres A. The production of pro-inflammatory cytokines (IL-6, IL-8) in human peritoneal fibroblasts is upregulated following stimulation with IL-lβ and/or TNFα. (Abstract) J Am Soc Nephrol 1994; 5: 463.

Nagata Y. , Matsumura F. , Motoyoski H. , Yamasaki H. , Fukuda K. , Tanaka S. Secretion of hyaluronic acid from synovial fibroblasts is enhanced by histamine: a newly observed metabolic effect of histamine. J Lab Clin Med 1992; 120: 707–12.

Laurent T.C. , Fraser J.R.E. The properties and turnover of hyaluronan. In: Evered D. , Whelan J. eds. Functions of proteoglycans. Ciba Foundation Symposium, vol. 124. Chichester: Wiley, 1986: 9–29.

Fessler J.H. , Fessler L.I. Biosynthesis of procollagen. Ann Rev Biochem 1978; 47: 129–62.

Rohde H. , Vargas L. , Hahn E. , Kalbfleisch H. , Bruguera M. , Timpl R. Radioimmunoassay for type III procollagen peptide and its application to human liver disease. Eur J Clin Invest 1979; 9: 451–9.

Shahin M. , Schuppan D. , Waldherr R. Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease. Hepatology 1992; 15: 637–44.

Parfitt A.M. , Simon L.S. , Villanueva A.R. , Krane S.M. Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with iliac bone formation rate and comparison with total alkaline phosphatase. J Bone Miner Res 1987; 2: 427–36.

Joffe P. , Jensen L.T. Type I and III procollagens in CAPD: markers of peritoneal fibrosis. In: Khanna R. , Nolph K.D. , Prowant B.F. , Twardowski Z.J. , Oreopoulos D.G. eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin Inc., 1991; 7: 158–60.

Digenis G.E. , Dombros N.V. , Christophoraki M. Procollagen type-1 in serum and dialysate of continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1993; 13(Suppl 2): S480–S483.

Krediet R.T. , Zemel D. , Imholz A.L.T. , Koomen G.C.M. , Struijk D.G. , Arisz L. Indices of peritoneal permeability and surface area. PeritDial Int 1993; 13(Suppl 2): S31S34.

Imholz A.L.T. , Koomen G.C.M. , Struijk D.G. , Arisz L. , Krediet R.T. Effect of dialysate osmolarity on the transport of low-molecular weight solutes and proteins during CAPD. Kidney Int 1993; 43: 1339–46.

Krediet R.T. , Zemel D. , Imholz A.L.T. , Struijk O.O. Impact of surface area and permeability on solute clearances. Perit Dial Int 1994; 14(Suppl 3): S70–S77.

Krediet R.T. , Zuyderhoudt F.M.J. , Boeschoten E.W. , Arisz L. Peritoneal permeability to proteins in diabetic and non-diabetic continuous ambulatory peritoneal dialysis patients. Nephron 1986; 42: 133–40.

Zemel D. , Krediet R.T. , Koomen G.C.M. , Struijk O.O. , Arisz L. Day-to-day variability of protein transport used as a method for analyzing peritoneal permeability in CAPD. Perit Dial Int 1991; 11: 217–23.

Rippe B. , Stelin G. Simulations of peritoneal solute transport during CAPD. Application of two-pore formalism. Kidney Int 1989; 35: 1234–44.

Nolph K.D. , Twardowski Z.J. , Popovich R.P. , Rubin J. Equilibration of peritoneal dialysis solutions during long-dwell exchanges. J Lab ClinMed 1979; 93: 246–56.

Heimburger O. , Waniewski J. , Werynski A. , Lindholm B. A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int 1992; 41: 1320–32.

Krediet R.T. , Zuyderhoudt F.M.J. , Boeschoten E.W. , Arisz L. Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients. Eur J Clin Invest 1987; 17: 43–52.

Pannekeet M.M. , Zemel D. , Koomen G.C.M. , Struijk D.G. , Krediet R.T. Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD. Perit Dial Int 1995; 15: 217–25.

Zemel D. , Koomen G.C.M. , Hart A.A.M. , ten Berge R.J.M. , Struijk D.G. , Krediet R.T. Relationship of TNFα, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med 1993; 122: 686–96.

Zemel D. , Struijk D.G. , Dinkla C. , Stolk L.M. , ten Berge R.J.M. , Krediet R.T. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in CAPD. J Lab Clin Med 1995; 126: 204–15.

Dobbie J.W. , Anderson J.D. , Hind C. Long-term effects of peritoneal dialysis on peritoneal morphology. Perit Dial Int 1994; 14(Suppl 3): S16–S20.

Ziegler C. , Torchia M. , Grahame G.R. , Ferguson I.A. Peritoneal surface-active material in continuous ambulatory peritoneal dialysis (CAPD) patients. Perit Dial Int 1989; 9: 47–9.

Krack G. , Viglino G. , Cavalli P.L. Intraperitoneal administration of phosphatidylcholine improves ultrafiltration in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1992; 12: 359–64.

Beavis J. , Harwood J.L. , Coles G.A. , Williams J.D. Intraperitoneal phosphatidylcholine levels in patients on continuous ambulatory peritoneal dialysis do not correlate with adequacy of ultrafiltration. J Am Soc Nephrol 1993; 3: 1954–60.

Pannekeet M.M. , Koomen G.C.M. , Struijk D.G. , Krediet R.T. Dialysate CA 125 in stable CAPD patients: no relation with transport kinetics. Clin Nephrol 1995; 44: 248–54.

Digenis G.E. , Dombros N.V. , Balaskas E.V. Procollagen-l and collagen-l in the serum and dialysate of CAPD patients. Changes over time. (Abstract) Perit Dial Int 1995; 15(Suppl 1): S52.

Struijk D.G. , Krediet R.T. , Koomen G.C.M. Functional characteristics of the peritoneal membrane in long-term continuous ambulatory peritoneal dialysis. Nephron 1991; 59: 213–20.

Struijk D.G. , Krediet R.T. , Koomen G.C.M. , Boeschoten E.W. , Hoek F.J. , Arisz L. A prospective study of peritoneal transport in CAPD patients. Kidney Int 1994; 45: 1739–44.

Monquil M.C. , Imholz A.L.T. , Struijk D.G. , Krediet R.T. Does impaired transcellular water transport contribute to net ultrafiltration failure during CAPD? Perit Dial Int 1995; 5: 42–8.

Dobbie J.W. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992; 12: 14–27.

Gandhi V.C. , Ing T.S. , Daugirdas J.T. , Hagen C. , Blumenkrantz M.J. , Jablokow V.R. Failure of peritoneal dialysis due to peritoneal sclerosis. Int J ArtifOrgans 1983; 6: 97.

Verger C. , Celicout B. Peritoneal permeability and encapsulating peritonitis. Lancet 1985; 1: 986–7.

Krediet R.T. , Struijk D.G. , Boeschoten E.W. The time course of peritoneal transport kinetics in continuous ambulatory peritoneal dialysis patients who develop sclerosing peritonitis. Am J Kidney Dis 1989; 13: 299–307.